Tradeshow
Feb 22, 2025 - Feb 26, 2025
Loews Philadelphia Hotel | 1200 Market St.| Philadelphia, PA 19107
US HUPO 2025

Discover the latest breakthrough solutions at 2025 US HUPO Conference in Philadelphia! Be sure to visit Thermo Fisher Scientific booth #7 to speak with our team of experts. This year we are hosting two lunchtime seminars - attend one or both. Seats are limited, so be sure to register today to secure your spot. Boxed lunches will be provided while supplies last.

Lunchtime seminars


Breakthroughs in proteomics: Unparalleled sensitivity and coverage

Monday, February 24, 2025 | 12:30 - 1:30 p.m. EST | Loews Philadelphia Hotel - Room: Commonwealth AB

To push the boundaries of modern proteomics, mass spectrometry must attain unprecedented sensitivity, accuracy, precision, and depth of coverage. Our goal is for mass spectrometers to explore biological systems with exceptional detail and specificity. Through collaboration with leading experts, we have developed innovative instruments and workflows to advance the field.

Register now to learn how the scientific community is addressing these challenges in areas like immunopeptidomics and spatial proteomics.


Talk 1: Optimized HLA class I and class II immunopeptidomics on the Orbitrap Astral mass spectrometer

Speaker:

Nicholas Cheung

Nicholas Cheung
Sr. Associate Scientist, Regeneron


Talk 2: High-resolution spatial proteomics using Syncell's microscoop and the Orbitrap Astral mass spectrometer

Speaker:

Azad Gucwa

Azad Gucwa
Sr. Field Application Scientist, Syncell

Innovating for impact: The future of translational research

Tuesday, February 25, 2025 | 12:30 - 1:30 p.m. EST | Loews Philadelphia Hotel - Room: Commonwealth AB

In the rapidly evolving field of translational disease research, the journey from biomarker discovery to clinical application is filled with challenges. Biomarker verification is a critical step that can determine the success of your research and its impact on patient outcomes. However, with the right tools and technologies, these obstacles can be transformed into opportunities for groundbreaking advancements.

Register now to discover how leading experts in academia and industry are overcoming these challenges as they seek to turn potential biomarkers into actionable insights. 


Talk 1: Advancing drug development: Insights into human disease with new proteomics tools

Speaker:

Ray Chen

Ray Chen
Senior Director, Olink, Part of Thermo Fisher Scientific


Talk 2: Quantitative proteomics on a nominal mass instrument to identify signatures of clinically related nephropathies

Speaker:

Dr. Luca Fornelli

Dr. Luca Fornelli
Assistant Professor, University of Oklahoma


Talk 3: New advances in translational proteomics

Speaker:

Bruce Wilcox

Bruce Wilcox
CTO, PrognomiQ

Posters


Monday, February 24, 2025 | 1:30 – 3:00 p.m. EST 

Revolutionizing translational research: large-scale targeted PRM proteomics assays enabled by Stellar mass spectrometer

Qingling Li

Comprehensive plasma Proteome profiling with Orbitrap Astral and pre-omics sample preparation kits for high-throughput biomarker discovery

Jared Deyarmin

High-throughput LC-MS Workflows for translational research of a mini cancer Cohort Using an Orbitrap Astral mass spectrometer

Kevin Yang

Unveiling hidden depths: a high-throughput plasma proteomics workflow for enhanced biomarker discovery

Kevin Yang

LC-MS workflows for diverse omics analysis of plasma samples in a mini cancer cohort using the Orbitrap Astral mass spectrometer

Rahul Deshpande

High-throughput workflow for targeted protein degradation compound screening on an Orbitrap Astral mass spectrometer with accurate quantitation

Kevin Yang

Enhancing immunopeptide profiling with Orbitrap Astral mass spectrometer for unbiased discovery of neoantigens

Fernanda Salvato

Label-free DIA-based workflow for single-cell proteomic analysis on an Orbitrap Ascend Tribrid mass spectrometer

Fernanda Salvato

A semi-targeted Orbitrap Tribrid Method for simultaneous quantification and discovery of immunopeptides

Tonya Hart

COOKIE-Pro: covalent inhibitor binding kinetics profiling on the proteome scale

Kevin Yang

High-throughput data-independent acquisition mass spectrometry workflow for in-depth identification of protein ubiquitination using an Orbitrap Astral mass spectrometerKevin Yang
Optimized XL-MS workflows for protein-protein and protein-nucleic acid interactions

Yi He

Simultaneous quantitation and discovery (SQUAD) metabolomics workflow on the Orbitrap IQ-X for the analysis of fecal bile acids

Bashar Amer

State-of-the-art glycopeptide identification using an Orbitrap Astral mass spectrometer

Julian Saba

Comprehensive multiomics integration: bridging proteomics and genomics

Khatereh Motamedchabo

Mass spectrometry-based proteomic investigation of patient-derived tumoroids using the Orbitrap Astral mass spectrometer informs precision oncology and drug discovery

Dominique Figueroa

Characterizing 32-plex TMTpro reagents for high-throughput quantitative proteomics on Orbitrap platforms

Dustin Frost

Streamlined automated proteomics sample preparation with novel magnetic beads

Amarjeet Flora 

Advancements in large-scale intact glycopeptide analysis: identification of novel glycopeptides and performance evaluation of Orbitrap mass spectrometerAmanda Lee
Ultra-sensitive quantitation and rapid method development for targeted immunopeptidomics using the Stellar mass spectrometerEllen Casavant
A novel tandem LC workflow for maximizing mass spectrometer utilizationlec Valenta
Maximizing low sample load coverage with 100 nL/min elution using 50cm long mesoporous pillar array columnsCristina Jacob
Enhancing protein quantification and sample throughput with the new TMTpro 32plex on Orbitrap Ascend Multiomics Tribrid mass spectrometerRafa Melani

Lunchtime seminars


Breakthroughs in proteomics: Unparalleled sensitivity and coverage

Monday, February 24, 2025 | 12:30 - 1:30 p.m. EST | Loews Philadelphia Hotel - Room: Commonwealth AB

To push the boundaries of modern proteomics, mass spectrometry must attain unprecedented sensitivity, accuracy, precision, and depth of coverage. Our goal is for mass spectrometers to explore biological systems with exceptional detail and specificity. Through collaboration with leading experts, we have developed innovative instruments and workflows to advance the field.

Register now to learn how the scientific community is addressing these challenges in areas like immunopeptidomics and spatial proteomics.


Talk 1: Optimized HLA class I and class II immunopeptidomics on the Orbitrap Astral mass spectrometer

Speaker:

Nicholas Cheung

Nicholas Cheung
Sr. Associate Scientist, Regeneron


Talk 2: High-resolution spatial proteomics using Syncell's microscoop and the Orbitrap Astral mass spectrometer

Speaker:

Azad Gucwa

Azad Gucwa
Sr. Field Application Scientist, Syncell

Innovating for impact: The future of translational research

Tuesday, February 25, 2025 | 12:30 - 1:30 p.m. EST | Loews Philadelphia Hotel - Room: Commonwealth AB

In the rapidly evolving field of translational disease research, the journey from biomarker discovery to clinical application is filled with challenges. Biomarker verification is a critical step that can determine the success of your research and its impact on patient outcomes. However, with the right tools and technologies, these obstacles can be transformed into opportunities for groundbreaking advancements.

Register now to discover how leading experts in academia and industry are overcoming these challenges as they seek to turn potential biomarkers into actionable insights. 


Talk 1: Advancing drug development: Insights into human disease with new proteomics tools

Speaker:

Ray Chen

Ray Chen
Senior Director, Olink, Part of Thermo Fisher Scientific


Talk 2: Quantitative proteomics on a nominal mass instrument to identify signatures of clinically related nephropathies

Speaker:

Dr. Luca Fornelli

Dr. Luca Fornelli
Assistant Professor, University of Oklahoma


Talk 3: New advances in translational proteomics

Speaker:

Bruce Wilcox

Bruce Wilcox
CTO, PrognomiQ

Posters


Monday, February 24, 2025 | 1:30 – 3:00 p.m. EST 

Revolutionizing translational research: large-scale targeted PRM proteomics assays enabled by Stellar mass spectrometer

Qingling Li

Comprehensive plasma Proteome profiling with Orbitrap Astral and pre-omics sample preparation kits for high-throughput biomarker discovery

Jared Deyarmin

High-throughput LC-MS Workflows for translational research of a mini cancer Cohort Using an Orbitrap Astral mass spectrometer

Kevin Yang

Unveiling hidden depths: a high-throughput plasma proteomics workflow for enhanced biomarker discovery

Kevin Yang

LC-MS workflows for diverse omics analysis of plasma samples in a mini cancer cohort using the Orbitrap Astral mass spectrometer

Rahul Deshpande

High-throughput workflow for targeted protein degradation compound screening on an Orbitrap Astral mass spectrometer with accurate quantitation

Kevin Yang

Enhancing immunopeptide profiling with Orbitrap Astral mass spectrometer for unbiased discovery of neoantigens

Fernanda Salvato

Label-free DIA-based workflow for single-cell proteomic analysis on an Orbitrap Ascend Tribrid mass spectrometer

Fernanda Salvato

A semi-targeted Orbitrap Tribrid Method for simultaneous quantification and discovery of immunopeptides

Tonya Hart

COOKIE-Pro: covalent inhibitor binding kinetics profiling on the proteome scale

Kevin Yang

High-throughput data-independent acquisition mass spectrometry workflow for in-depth identification of protein ubiquitination using an Orbitrap Astral mass spectrometerKevin Yang
Optimized XL-MS workflows for protein-protein and protein-nucleic acid interactions

Yi He

Simultaneous quantitation and discovery (SQUAD) metabolomics workflow on the Orbitrap IQ-X for the analysis of fecal bile acids

Bashar Amer

State-of-the-art glycopeptide identification using an Orbitrap Astral mass spectrometer

Julian Saba

Comprehensive multiomics integration: bridging proteomics and genomics

Khatereh Motamedchabo

Mass spectrometry-based proteomic investigation of patient-derived tumoroids using the Orbitrap Astral mass spectrometer informs precision oncology and drug discovery

Dominique Figueroa

Characterizing 32-plex TMTpro reagents for high-throughput quantitative proteomics on Orbitrap platforms

Dustin Frost

Streamlined automated proteomics sample preparation with novel magnetic beads

Amarjeet Flora 

Advancements in large-scale intact glycopeptide analysis: identification of novel glycopeptides and performance evaluation of Orbitrap mass spectrometerAmanda Lee
Ultra-sensitive quantitation and rapid method development for targeted immunopeptidomics using the Stellar mass spectrometerEllen Casavant
A novel tandem LC workflow for maximizing mass spectrometer utilizationlec Valenta
Maximizing low sample load coverage with 100 nL/min elution using 50cm long mesoporous pillar array columnsCristina Jacob
Enhancing protein quantification and sample throughput with the new TMTpro 32plex on Orbitrap Ascend Multiomics Tribrid mass spectrometerRafa Melani

Featured products


Orbitrap Astral Mass Spectrometer
The Thermo Scientific Orbitrap Astral Mass Spectrometer combines three mass analyzers: a quadrupole mass analyzer for high selectivity and high ion transmission, an Orbitrap mass analyzer for high dynamic range and high resolution measurements, and the novel Astral analyzer for fast and sensitive measurements. By combining these three mass analyzers and orchestrating the coordination of 5 separate ion packets within the instrument in parallel a new standard for mass spectrometry performance is achieved to unlock new insights into biology and disease mechanisms.

Stellar Mass Spectrometer
The Thermo Scientific Stellar Mass Spectrometer introduces groundbreaking technology that merges robust quantitation with the precision of rapid full scan MSn acquisition, significantly enhancing laboratory productivity. This mass spectrometer sets a new standard for targeted quantitation, allowing for more efficient, confident, and cost-effective progression of biomarker candidates from discovery to validation. It features advancements in scalability, throughput, sensitivity, specificity, and overall productivity.

Thermo Scientific AccelerOme automated sample preparation platform
The AccelerOme automated sample preparation platform, with factory-supplied reagents and kits,  intuitive software and a unique experimental design experience transforms proteomics sample preparation.

Vanquish Neo UHLPC System
Designed for researchers pursuing their next scientific breakthrough, the Vanquish Neo UHPLC system is ideal for LC-MS applications in proteomics, precision medicine, translational research, and more. Combine with Thermo Scientific PepMap Neo nano-flow LC columns for unmatched efficiency and robust performance for shallow gradients, high-throughput applications, and everything in between.

Register to attend our lunchtime seminars!

* Required field